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The R7 regulator of G protein signaling family (R7-RGS) crit-
ically regulates nervous systemdevelopment and function.Mice
lacking all R7-RGS subtypes exhibit diverse neurological pheno-
types, and humans bearing mutations in the retinal R7-RGS
isoform RGS9-1 have vision deficits. Although each R7-RGS
subtype formsheterotrimeric complexeswithG5 andR7-RGS-
binding protein (R7BP) that regulate G protein-coupled
receptor signaling by accelerating deactivation of Gi/o -sub-
units, several neurological phenotypes of R7-RGS knock-out
mice are not readily explained by dysregulated Gi/o signaling.
Accordingly, we used tandem affinity purification and LC-
MS/MS to search for novel proteins that interact with R7-RGS
heterotrimers in the mouse brain. Among several proteins
detected, we focused on G13 because it had not been linked to
R7-RGS complexes before. Split-luciferase complementation
assays indicated that G13 in its active or inactive state inter-
acts with R7-RGS heterotrimers containing any R7-RGS iso-
form. LARG (leukemia-associated Rho guanine nucleotide
exchange factor (GEF)), PDZ-RhoGEF, and p115RhoGEF
augmented interaction between activated G13 and R7-RGS
heterotrimers, indicating that these effector RhoGEFs can
engage G13R7-RGS complexes. Because G13/R7-RGS inter-
action required R7BP, we analyzed phenotypes of neuronal cell
lines expressingRGS7 andG5with orwithoutR7BP.We found
that neurite retraction evoked by G12/13-dependent lysophos-
phatidic acid receptors was augmented in R7BP-expressing
cells. R7BP expression blunted neurite formation evoked by
serum starvation by signaling mechanisms involving G12/13
but not Gi/o. These findings provide the first evidence that
R7-RGS heterotrimers interact with G13 to augment signaling
pathways that regulate neuritemorphogenesis. Thismechanism
expands the diversity of functions whereby R7-RGS complexes
regulate critical aspects of nervous system development and
function.
Regulator of G protein signaling (RGS)2 proteins regulate the
amplitude and kinetics of G protein-coupled receptor signaling
by functioning in part as GTPase-activating proteins (GAPs)
that accelerate the rate that G protein -subunits hydrolyze
GTP to GDP (1). Among30 mammalian proteins containing
an RGS domain, the R7 regulator of G protein signaling family
(R7-RGS), consisting of RGS6, RGS7, RGS9, and RGS11, is par-
ticularly important. R7-RGS proteins are highly expressed in
the nervous system and exhibit GAP activity in vitro only for
Gi/o (2–7). Humans bearing mutations in the retinal RGS9-1
isoform exhibit a vision deficit termed bradyopsia (8), andmice
lacking selected or all R7-RGS proteins exhibit various neuro-
logical phenotypes manifested by impairment of perinatal
viability, weight gain, retina structure and function, neurobe-
havioral development, motor coordination, cerebellar and
hippocampal development, and analgesic response to opioids
(9–12), thereby establishing these regulators as crucial players
in neurological development and function.
Evidence suggests that R7-RGS proteins have diverse mech-
anistic functions beyond serving as Gi/o-specific GAPs. First,
in contrast to several other classes of RGS proteins that are
GAPs forGi/o-subunits (13), R7-RGSproteins are structurally
complex. Each R7-RGS isoform possesses N-terminal dishev-
eled, Egl-10, and pleckstrin (DEP), DEP helical extension
(DHEX), and G protein -like (GGL) domains followed by a
C-terminal RGS domain that is necessary and sufficient for
GAP activity. The GGL domain binds the most diverged mem-
ber of the G family, G5 (4, 14), to form obligate heterodi-
meric complexes structurally similar to classical G dimers
(15). The DEP domain interacts with either of two SNARE-like
membrane anchor proteins (16–21), R7-RGS-binding protein
(R7BP) and RGS9 anchor protein (R9AP), to form R7-RGS het-
erotrimers. Whereas R9AP is a transmembrane protein local-
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ized to photoreceptor disk membranes, R7BP is reversibly and
dynamically palmitoylated to regulate plasmamembrane local-
ization of R7-RGS heterotrimers throughoutmuch of the nerv-
ous system (17, 22–24). Second, as shown in Caenorhabditis
elegans, the N-terminal DEP/DHEX domain rather than the
RGS domain of R7-RGS proteins determines which neurologi-
cal processesmediated by distinctGproteins are regulated (25).
Third, RGS7G5 and RGS9-2G5 complexes, respectively,
can attenuate Gq-coupled type 3 muscarinic or Gi/o-coupled
type 3 dopamine receptors by GAP-independent mechanisms
(19, 21), similar to other structurally complexRGSproteins that
serve as multifunctional regulators, integrators, and/or effec-
tors in signaling networks (26, 27). Lastly, RGS6 can scaffold
DNA methyltransferase 1 to the acyltransferase Tip60 to pro-
mote DNAmethyltransferase 1 degradation in response to Ras
activation in mouse embryonic fibroblasts (28, 29).
Despite such evidence, whether the membrane anchor R7BP
is required for functions of R7-RGS complexes other than Gi/
o-specific GAP activity has not been investigated. Here we have
addressed this question by using a proteomics approach to
identify proteins that interact with R7BP-bound R7-RGS com-
plexes in mouse brain. Our results expand understanding of
R7BP-bound R7-RGS complexes by indicating that they facili-
tate G13 signaling to regulate neurite morphogenesis.
Results
RGS7, G5, and R7BP formmacromolecular complexes larger
than simple heterotrimers in neuronal cells
If R7BP-bound R7-RGS proteins have novel functions, they
would be expected to participate in novel protein-protein inter-
actions. Accordingly, we investigated whether RGS7, G5, and
R7BP exist in macromolecular complexes larger than simple
heterotrimers in living cells. We used Neuro2a (N2a) cells
endogenously expressing RGS7 and G5 and stably transfected
with N-terminally FLAG-tagged R7BP at physiologically nor-
mal levels (5) that were treated with vehicle or disuccinimidyl
suberate (DSS), a cell-permeable, amine-reactive cross-linker.
Cell lysates were immunoprecipitated with FLAG antibody,
resolved via SDS-PAGE, and immunoblotted to detect G5, the
obligate core subunit of all R7-RGS complexes. As expected if
additional proteins associate with R7-RGS heterotrimers, this
approach detected several distinct species with relative molec-
ular weights larger than R7-RGS heterotrimers (Fig. 1A). These
experiments also detected non-cross-linked G5 and cross-
linked R7-RGSG5FLAG-R7BP heterotrimers (Fig. 1A).
These results are consistent with an independent study in
which complexes containing R7BP were detected in lysates of
transfected HEK293T cells and mouse brain lysates cross-
linked with paraformaldehyde (30).
Generation of transgenicmice expressing tandem affinity
purification (TAP)-tagged R7BP
To identify potentially novel proteins that associate with
R7BP-containing R7-RGS heterotrimers, we isolated these
complexes from brain tissue by affinity purification and identi-
fied proteins recoveredwith these complexes by liquid chroma-
tography-coupled tandem mass spectrometry (LC-MS/MS).
This approach was motivated by prior studies showing that the
membrane anchor R9AP and transducin -subunits co-purify
with RGS9-1G5 heterodimers in photoreceptor membranes
(20) and that an orphan G protein-coupled receptor (GPR158)
associates with RGS7G5 heterodimers in brain lysates (18,
31). However, our approachwas novel because it identified pro-
teins that associate with heterotrimers containing any R7-RGS
isoform, G5, and R7BP.
We developed a TAP strategy in which the FLAG-StrepII-
StrepII tag (32) was appended to the N terminus of R7BP (SF-
R7BP; Fig. 1B) and generated transgenic mice expressing this
protein specifically in neurons. This was accomplished by driv-
ing SF-R7BP expression from the mouse prion promoter upon
integration of the transgene in single copy at the X-linkedHprt
locus (33, 34) (Fig. 1B). As indicated by immunoblotting with
anti-R7BP antibodies, SF-R7BP and endogenously expressed
R7BP were expressed similarly in various brain regions and
were undetectable in heart and kidney (Fig. 1C). Importantly,
SF-R7BP was not overexpressed relative to endogenous R7BP,
reducing concern of identifying biologically irrelevant protein-
protein interactions due to overexpression. SF-R7BP protein
expression profiles were similar in three independently derived
transgenic lines, all of whichwere used for TAP experiments. In
all subsequent experiments, SF-R7BP-expressing adult male
mice were used to avoid potentially mosaic expression of
SF-R7BP due to X chromosome inactivation in females.
Tandem affinity purification and LC-MS/MS analysis of R7BP-
containing protein complexes
R7BP-containing protein complexes were isolated from the
combined lysates of three SF-R7BP adult male mouse brains as
detailed under “Experimental procedures.” The purification
Figure 1. Generation of SF-R7BP transgenic mice to identify novel pro-
teins that interact with R7-RGS heterotrimers. A, live-cell chemical cross-
linking. N2a cells lacking or stably expressing 3xFLAG-R7BPwere treatedwith
DSS followed by immunoprecipitation (IP) of R7BP-containing cross-linked
complexes. Immunoprecipitation eluates were separated by SDS-PAGE and
immunoblotted for G5 (shown), RGS7, and R7BP (not shown). The band cor-
responding to R7-RGS heterotrimers was indicated by detection with G5,
RGS7, and R7BP antibodies. Data shown are representative of three indepen-
dent experiments. B, SF-R7BP transgenic mice were generated by targeting
SF-R7BP in reverse orientation to the Hprt locus on the X chromosome as
described under “Experimental procedures.” SF-R7BP expression was by the
neuron-specificMoPRP. C, Western blot (WB) analysis of lysates from the indi-
cated brain regions and other organs from non-transgenic control and
SF-R7BP transgene-positive male mice. Wild-type untagged R7BP was
expressed from its endogenous locus. Data are representative of three inde-
pendent SF-R7BP transgenic lines.
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procedure was optimized to achieve low nonspecific protein
binding as indicated by SYPRO Ruby staining of TAP eluates
from control non-transgenic mice relative to SF-R7BP trans-
genicmice (Fig. 2A).Moreover, the purification conditions pre-
served R7-RGS heterotrimers as indicated by immunoblotting
showing that G5 and RGS7 co-purified with SF-R7BP
(Fig. 2B).
Proteins that co-purified with R7-RGS heterotrimers were
identified by resolvingTAPFLAGeluates on SDS-PAGE, excis-
ing and extracting SYPRO Ruby-stained gel bands, and digest-
ing with Glu-C and trypsin (Fig. 2C). The resulting peptides
were sequenced by LC-MS/MS, and the corresponding pro-
teins were identified as described under “Experimental proce-
dures.” Detailed peptide and protein identification data are
summarized in Table 1 and supplemental Table 1. As expected,
SF-R7BP (denoted in Table 1 as Rgs7bp protein), G5, and
three of the four R7-RGS isoforms (RGS11 was not detected,
presumably due to limited expression in brain) were identified
(Table 1 and supplemental Table 1). Go, which is a substrate
for the GAP function of R7-RGS heterotrimers, also was iden-
tified with high confidence.
G13 is a novel binding partner of R7-RGS heterotrimers
G13 was identified with high confidence in our LC-MS/MS
analysis of proteins that co-purified with SF-R7BP-bound
R7-RGS complexes (Table 1 and supplemental Table 1). Simi-
larly, G13 was identified in TAP-LC-MS/MS experiments
using N2a cells expressing SF-R7BP (data not shown).
Although unique peptides diagnostic of other G isoforms or
classical G subunits were not detected, we cannot exclude
that these proteins were present in R7-RGS complexes bound
to SF-R7BP.
Recovery of G13 was intriguing for two reasons. First, G13
is not a substrate for the GAP function of R7-RGS heterotrim-
ers that is specific in vitro for Gi/o subunits (2–4). Therefore,
co-purification of G13 with R7-RGS complexes suggested that
R7-RGS heterotrimers potentially influence the function of this
G subunit by GAP-independent mechanisms. Second, mice
deficient in all R7-RGS heterotrimers due to knock-out of the
shared obligate subunit G5 have abnormal dendriticmorphol-
ogy as seen in retinalON-bipolar and Purkinje neurons (10, 11).
Because G13 is a well established regulator of the actin cyto-
skeleton, which regulates dendritic morphogenesis, a func-
tional relationship between R7-RGS heterotrimers and G13
might account in part for the dendriticmorphology phenotypes
of G5/ mice. Accordingly, the remainder of the present
study focused on the interaction between R7-RGS heterotrim-
ers and G13.
To provide independent evidence whether G13 can associ-
ate with R7-RGS heterotrimers, we adopted split-luciferase
complementation assays to assess protein-protein interactions
in living cells (35, 36). Because split-luciferase complementa-
tion apparently had not been used before with G subunits, we
first determined whether this technique is appropriate for our
purposes. We inserted the N-terminal fragment of click beetle
green luciferase (CBGN; Ref. 36) into the B-C loop of the
helical domain in wild-type and constitutively active (i.e.
GTPase-defective Gln3 Leu (Q/L)mutants) forms of Gq and
G13 because insertion of GFP at this site preserves G func-
tion (37). The C-terminal fragment of click beetle green lucif-
erase (CBGC) was fused to the N termini of the following pro-
teins: RGS2 (CBGC-RGS2), a GAP for Gq but not G13; the
RH-RGS domain of LARG (CBGC-LARGRGS), a GAP for
G13 but not Gq; and G1 (CBGC-G1). These constructs
were used to determine whether split-luciferase complemen-
tation detects specific and activity-dependent interaction
between Gq or G13 and their cognate binding partners in
intact cells.
This expectation was confirmed by results of luciferase
assays performed with HEK293 cells co-transfected with vari-
ous combinations of split luciferase-tagged proteins (Fig. 3A).
Wild-type CBGN-tagged Gq or G13 complemented strongly
with CBGC-G1 co-transfected with G2. Constitutively ac-
tive G13(Q/L)-CBGN complimented strongly with CBGC-
LARGRGS but not CBGC-RGS2. Likewise, constitutively
Gq(Q/L)-CBGN complemented strongly with CBGC-RGS2
but not CBGC-LARGRGS. Wild-type G13-CBGN and
Gq-CBGN complemented insignificantly, respectively, with
CBGC-LARGRGS and CBGC-RGS2. Thus, split-luciferase
complementation detected specific protein-protein interac-
tions determined by G subunit identity and activation state.
Split-luciferase complementation then was used to study
interaction between G13 and R7-RGS heterotrimers and to
determine whether this interaction is affected by the activity
state of G13. In these experiments, HEK293 cells were co-
transfected with CBGC-FLAG-G5, HA-RGS7 with or without
FLAG-R7BP, various G-CBGN constructs, and Renilla lucif-
erase as a transfection control. When co-expressed with
HA-RGS7 and FLAG-R7BP, CBGC-FLAG-G5 strongly com-
plemented with either wild-type or constitutively active G13-
CBGN but not with wild-type or constitutively active Gq-
CBGN (Fig. 3B). These results confirmed that R7-RGS
heterotrimers and G13 interact in a specific manner rather
than by nonspecific collisional interaction within the plane of
theplasmamembraneandindicatedthat this interactionis inde-
pendent of G13 activation. These interactions required the
Figure 2. TAP of SF-R7BP and interacting proteins frommouse brain. A,
assessingnonspecific background in TAPexperiments. TAPwasperformedas
described under “Experimental procedures” using detergent-solubilized
brainhomogenates fromeither threeSF-R7BP-positiveor threeSF-R7BP-neg-
ative male mice as indicated. The final eluates were separated by SDS-PAGE,
and proteins were visualized by SYPRO Ruby staining. B, Western blot (WB)
analysis of SF-R7BP,G5, andRGS7 for each stepof theTAPprotocol.C, SYPRO
Ruby-stainedgel of theTAPeluate fromthreeSF-R7BP-positivemousebrains.
Arrows indicate regions of the gel that were excised and analyzed by LC-MS/
MS.Mass spectrometrydata summarized in Table 1 and supplemental Table 1
are organized by gel slice numbers indicated in this panel.
R7-RGS regulation of neuritemorphogenesis
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presence of R7BP (Fig. 3B), presumably because palmitoylated
R7BP targets R7-RGSG5 complexes to the plasmamembrane
where G13 localizes.
Next we used split-luciferase complementation to determine
whether complexes containing any R7-RGS isoform can inter-
act with G13 or whether particular R7-RGS family members
are preferred. For these experiments, HEK293 cells were trans-
fectedwithG13(Q/L)-CBGNandCBGC-FLAG-G5with var-
ious R7-RGS isoforms in the presence or absence of R7BP.
Because the proteolytic stability of G5 varies depending on
which R7-RGS isoform is expressed in the presence or absence
of R7BP and because luciferase signals depend on the expres-
sion level of CBGC-FLAG-G5, we normalized split-luciferase
signals in these experiments to the expression of CBGC-FLAG-
G5 determined by immunoblotting (Fig. 3D). Normalization
for G13(Q/L)-CBGN expression was unnecessary because this
protein was well expressed with or without RGS7 or R7BP as
indicated by immunoblotting of glutamate-glutamate (EE)-
Table 1
Subset of proteins identified by LC-MS/MS analysis of TAP fractions
Protein bands marked with an arrow in Fig. 2C were analyzed by LC-MS/MS to identify proteins that co-purified with SF-R7BP from transgenic mouse brain. Peptide
identifications were accepted if they could be established at greater than 80% probability by the Scaffold local false discovery rate algorithm. All proteins shown here have
at least a 99% protein identification (ID) probability as determined using the Protein Prophet algorithm and at least two exclusive unique peptides assigned. Tabulated are
protein identification information for R7BP (Rgs7bp protein); R7-RGS family members; and G5, Go, and a novel interacting protein, G13. See supplemental Table 1 for
a complete list of all proteins identified and peptide sequence information.














6 Rgs7bp protein (Mus musculus) gi 111600355 100.00 3 4 12 19.50
7 Rgs7bp protein (M. musculus) gi 111600355 100.00 3 4 87 13.60
8 Rgs7bp protein (M. musculus) gi 111600355 100.00 2 3 73 22.60
2 Regulator of G-protein signaling 9 isoform 1 (M. musculus) gi 146134422 100.00 5 7 21 24.30
3 Regulator of G-protein signaling 9 isoform 1 (M. musculus) gi 146134422 100.00 4 4 14 18.70
4 Regulator of G-protein signaling 6 (M. musculus) gi 29789076 100.00 6 8 15 20.30
5 Regulator of G-protein signaling 6 (M. musculus) gi 29789076 100.00 7 9 11 18.60
4 Regulator of G-protein signaling 7 (M. musculus) gi 312222673 100.00 9 11 26 21.70
5 Regulator of G-protein signaling 7 (M. musculus) gi 312222673 99.90 5 6 12 12.30
6 Guanine nucleotide-binding protein subunit 5 isoform 2
(M. musculus)
gi 41281679 100.00 4 5 5 5.67
7 Guanine nucleotide-binding protein subunit 5 isoform 2
(M. musculus)
gi 41281679 100.00 17 20 25 26.10
8 Guanine nucleotide-binding protein subunit 5 isoform 2
(M. musculus)
gi 41281679 100.00 5 6 6 8.22
9 Guanine nucleotide-binding protein subunit 5 isoform 2
(M. musculus)
gi 41281679 100.00 3 4 4 5.67
10 Guanine nucleotide-binding protein subunit 5 isoform 2
(M. musculus)
gi 41281679 100.00 2 3 3 5.10
7 Guanine nucleotide-binding protein subunit 13 (M.
musculus)
gi 89001109 100.00 2 2 3 10.10
7 Guanine nucleotide-binding protein Go subunit  isoform B
(M. musculus)
gi 164607137 99.00 2 2 3 7.63
Figure 3. R7BP is required to detect interaction betweenG13 and R7-RGS complexes containing any R7-RGS familymember. A, proof of concept that
split-luciferase complementation detects protein-protein interactions specific for G subunit identity and activity state. Data are represented as the -fold
difference in normalized split-luciferase signal relative to the positive control for each G-CBGN construct. Data shown are the average of three independent
experiments. B, split-luciferase complementation between the indicated G-CBGN proteins and CBGC-G5RGS7 with or without R7BP. Each box represents a
data point from one of three independent experiments. C, split-luciferase complementation between G13(Q/L)-CBGN and CBGC-3xFLAG-G5 co-expressed
with each R7-RGS isoformwith or without R7BP. Luciferase signals were normalized to the level of CBGC-3xFLAG-G5 expression determined by immunoblot-
ting. Each box represents a data point from one of five independent experiments. D, representative FLAGWestern blot (WB) showing CBGC-3xFLAG-G5 and
3xFLAG-R7BP expression for each condition in C. The band marked with an asterisk is a degradation product of CBGC-3xFLAG-G5. E, G13(Q/L)-CBGN-EE
expression does not change with co-expression of R7-RGS heterotrimer proteins. Shown are representative immunoblots for C. Error bars indicate standard
deviation of the mean. Statistical significance was determined using two-tailed, two-sample Student’s t test assuming equal or unequal variance as deemed
appropriate by F-test analysis. *, p 0.05; **, p 0.01; ***, p 0.001; n.s., p 0.05.
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tagged G13(Q/L)-CBGN (Fig. 3E). Data analyzed in this way
showed efficient luciferase complementationwhenG13(Q/L)-
CBGN was co-expressed with CBGC-FLAG-G5, R7BP, and
any R7-RGS family member, whereas complementation was
low in the absence of either an R7-RGS subunit or R7BP (Fig.
3C). Therefore, G13 interacted in living cells with heterotrim-
ers bearing R7BP, G5, and any R7-RGS isoform.
R7-RGS heterotrimers augment neurite retraction evoked by
G13-coupled lysophosphatidic acid (LPA) receptors
To determine whether R7-RGS heterotrimers affect biologi-
cal processes driven byG13 and its close paralogG12, we took
advantage of studies showing that G12/13 signaling causes
growth cone collapse and neurite retraction in cultured neu-
rons and neuronal cell lines (38–44). Accordingly, we deter-
mined whether R7-RGS heterotrimers affect neurite retraction
in differentiated N2a cells. N2a cells were chosen as a model
because they elaborate neurites when differentiated by serum
starvation, and expression of constitutively active G13 or
RhoA in these cells antagonizes neurite elaboration (40, 44).
Moreover, N2a cells endogenously express RGS7 and G5 but
lack R7BP (5), which allowed us to compare G12/13-driven
processes in the absence or presence of R7BP stably transfected
at physiological levels to promote interaction of R7-RGS com-
plexes with G13.
LPA evokes neurite retraction in primary neurons by activat-
ing receptors coupled toG12/13 (41, 42).Whether LPA triggers
neurite retraction in N2a cells had not been established,
although this seemed likely because expression of constitutively
active G13 in these cells antagonizes neurite formation. To
address this question, we differentiatedN2a cells by serum star-
vation and treated themwith LPA for 15min. After fixation and
permeabilization, cells were stained with rhodamine-phalloi-
din to visualize neurites and actin organization. We found that
LPA treatment robustly evoked neurite retraction (Fig. 4,A–C).
Because LPA receptors can couple to Gi/o, Gq/11, Gs, and G12/13
(45), we determined whether LPA-induced neurite retraction
in differentiated N2a cells is mediated by G12/13 signaling. To
address this question, we inhibited G12/13 signaling by overex-
pressing a truncated HA-tagged version of p115-RhoGEF (HA-
p115RGS) that is targeted to the plasmamembrane by a prenyla-
tionmotif and retainsGAPactivity forG12/13 but cannot activate
RhoA (46). Expression of HA-p115RGS blocked LPA-induced
neurite retraction in differentiatedN2a cells (Fig. 4,A–C), indicat-
ing that G12/13 signaling is indeed required for this process.
Based on the preceding results, we investigated whether
R7-RGS heterotrimers can regulate LPA-induced neurite
retraction. Because R7BP facilitates interaction between
R7-RGS complexes and G13, we compared the effects of LPA
on N2a cells, which express RGS7 and G5 but lack R7BP (5),
with N2a cells stably expressing FLAG-R7BP at physiological
levels (5). Results indicated that LPA-evoked neurite retraction
was augmented in cells expressing FLAG-R7BP (Fig. 4, D and
E), suggesting that R7BP-bound R7-RGS complexes augment
signaling by G12/13-coupled LPA receptors.
Figure 4. R7BP augments neurite retraction evoked by activation of G12/13-coupled LPA receptors or serum starvation. Rhodamine-phalloidin stain-
ing and fluorescencemicroscopywere used to visualize neurites and cell morphology. Cells were scored by counting the number of neurites elaborated from
the cell body that were greater than half the cell body diameter. At least 50 cells were scored per condition per experiment. A, representative fluorescence
images of parental N2a cells transfectedwith either GFP (control) or HA-p115RGS and treatedwith vehicle (veh) or 10M LPA. Control experiments confirmed
antibody staining specificity (data not shown). B, quantification of neurites formed per cell under conditions shown in A. Data shown are the average of three
independent experiments. C, number of cells with neurites under conditions shown in A. Each box represents a data point from one of three independent
experiments.D, representative fluorescence imagesofparentalN2aorN2a cells stably expressingFLAG-R7BP treatedwith the indicated concentrationsof LPA.
E, quantification of neurite formation under conditions shown inD. Each box represents a data point fromone of four independent experiments. Scale bars, 50
m. Error bars indicate standard deviation of the mean. Statistical significance was determined using two-tailed, two-sample Student’s t test assuming equal
or unequal variance as deemed appropriate by F-test analysis. *, p 0.05; **, p 0.01. Proj., projection.
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In the preceding experiments, we also noted that, prior to
LPA stimulation, R7BP expression antagonized neurite forma-
tion evoked by serum starvation alone (Fig. 4, D and E). To
explore the mechanisms involved, we tested twomodels. In the
first model, R7BP expression enables R7-RGS complexes
to augment serum starvation-evoked G12/13 signaling, which
attenuates neurite formation. If so, inhibiting G12/13 activity
would be expected to rescue neurite formation in N2a cells
stably expressing FLAG-R7BP. To test this prediction, FLAG-
R7BP-expressing N2a cells were transiently transfected with
HA-p115RGS or a GFP-expressing control plasmid, differenti-
ated, and analyzed for neurite formation. Results indicated that
neurite formation trended higher butwas incompletely rescued
in cells transiently expressing HA-p115RGS as compared with
controls (Fig. 5,A and B; p 0.24). Thus, R7BP-bound R7-RGS
heterotrimers appeared to regulate neurite morphogenesis
under basal conditions in serum-starved cells by mechanisms
that depend partly on G12/13 signaling.
One potential explanation for the preceding result is pro-
vided by a second model in which R7BP-bound R7-RGS com-
plexes regulate neuritemorphogenesis in serum-starved cells in
part by attenuating Gi/o signaling. Indeed, Gi/o-coupled canna-
binoid type 1 receptor signaling promotes neurite outgrowth in
N2a cells (47, 48), which potentially could be negatively regu-
lated by the GAP activity of R7BP-bound R7-RGS complexes
(17, 23, 49–51). However, whether Gi/o activity in N2a cells
promotes neurite formation in response to serum starvation
had not been tested. We found that this appeared not to be the
case because blocking Gi/o activation with pertussis toxin
(PTX) did not inhibit neurite formation evoked by serum star-
vation (Fig. 5,C andD) in contrast to control experiments dem-
onstrating that PTX treatment strongly inhibited the ability of a
cannabinoid type 1 agonist (WIN 55,212-2) to blunt forskolin-
evoked cAMP accumulation detected with a FRET reporter
(Fig. 5, E and F). Therefore, these results argued against models
in which R7BP-bound R7-RGS complexes promote neurite
retraction by attenuating Gi/o signaling.
Lastly, we explored how R7BP augments G13-dependent
neurite retraction by studying G13-activated RhoGEFs
(LARG, p115RhoGEF, and PDZ-RhoGEF) that mediate RhoA
activation and consequent neurite retraction. Our initial
approach relied on prior investigations showing that these Rho-
GEFs can be recruited to the plasma membrane by activated
G13 (46). Thus, if R7BP-bound R7-RGS complexes promote
G13 signaling, then expression of R7BP in N2a cells might be
expected to augment plasma membrane recruitment of these
RhoGEFs. However, by confocal imaging, we were unable to
detect differences in plasma membrane recruitment of GFP-
tagged LARG, p115RhoGEF, or PDZ-RhoGEF in response to
LPA and/or R7BP expression (data not shown).
As an alternative approach that might provide greater sensi-
tivity, we determined whether RhoGEFs affect interaction
between constitutively active G13 and R7BP-bound R7-RGS
complexes in split-luciferase complementation assays. Rather
than assessing G13 activity, this approach addressed the key
question whether complexes containing activated G13 and
R7-RGS heterotrimers are capable of physically engaging effec-
tor RhoGEFs that trigger RhoA activation and neurite retrac-
tion. Accordingly, HEK293 cells were transfectedwithG13(Q/
L)-CBGN, CBGC-FLAG-G5, RGS7, and R7BP in the absence
or presence of Myc-tagged forms of LARG, p115RhoGEF, or
PDZ-RhoGEF. As shown in Fig. 6, split-luciferase complemen-
tation resulting from interaction between activated G13 and
R7BP-bound RGS7-G5 complexes was increased 7-fold by
LARG, 4-fold by PDZ-RhoGEF, and 2-fold by p115RhoGEF.
Accordingly, the results of these and preceding experiments
support models in which R7BP-bound R7-RGS complexes
interact with G13 in neuronal cells to augment signaling
mechanisms that promote neurite retraction and blunt neurite
formation.
Discussion
Our findings are the first to indicate that R7-RGS hetero-
trimers form macromolecular complexes with G13 and con-
Figure 5. G12/13 activity rather thanGi/o activity regulates neurite for-
mation by serum-starved N2a cells. N2a cells lacking or stably expressing
3xFLAG-R7BP were plated, differentiated, fixed, stained, and scored as
described in Fig. 4 and under “Experimental procedures.” A, representative
fluorescence images of cells stably expressing FLAG-R7BP and transfected
with either GFP (control) or HA-p115RGS. B, quantification of neurite forma-
tion under conditions shown in A. In these experiments, all cells quantified
were transfected, whereas those in Fig. 4Ewere not transfected, which likely
explains why the percentage of R7BP-expressing cells bearing neurites in
response to serum starvation was different between the two types of exper-
iments. Each box represents a data point from one of three independent
experiments. C, representative fluorescence images of parental N2a cells
treated with PTX.D, quantification of the neurites formed by cells under con-
ditions described in C. Each box represents a data point from one of four
independent experiments. E, inhibition of Gi/o signaling by PTX in N2a cells.
N2a cells were transfectedwith the cAMP FRET sensor Epac-SH187 and treated
for 16–24 h with or without 100 ng/ml PTX. Baseline cAMP levels were
recorded for 1 min, and then cells were treated with 25 M forskolin (FSK) to
stimulate cAMP production. After 5 min of forskolin treatment, endogenous
Gi/o-coupled cannabinoid type1 receptorswere activatedby additionof 5M
WIN 55,212-2 (WIN), and cAMP levels were recorded for an additional 5 min.
Data shown are the averages of three independent experiments. F, quantifi-
cation of percent maximum cAMP levels after WIN 55,212-2 stimulation as
shown inE. Percentmaximum(%max) cAMP [(minimumF/F0)/(maximum
F/F0)] 100. Each box represents a data point from one of three indepen-
dent experiments. Scale bars, 50m. Error bars indicate standard deviation of
themean. Statistical significancewas determined using two-tailed, two-sam-
ple Student’s t test assuming equal variance as deemed appropriate by F-test
analysis. ***, p 0.001; n.s., p 0.05. Proj., projection.
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trol neuritemorphogenesis regulated in part byG12/13-depend-
ent signaling. Accordingly, they expand the functional
diversity of R7-RGS heterotrimers beyond their canonical roles
as GAPs for Gi/o. Because genetic ablation of R7-RGS com-
plexes affects diverse aspects of neurological development and
function (9–12), our findings suggest that R7-RGS heterotrim-
ers potentially regulate certain processes in part by augmenting
G13 signaling rather than solely by attenuating Gi/o signaling.
Indeed, certain phenotypes of mice lacking R7-RGS hetero-
trimers are not recapitulated in mice expressing RGS-insensi-
tive mutant forms of Go or Gi (52).
Several prior lines of evidence are consistent with the
hypothesis that R7-RGSheterotrimers regulateG12/13 signaling
to control nervous systemdevelopment. R7-RGS heterotrimers
are dramatically up-regulated during postnatal brain develop-
ment as synapses mature (5, 53). Mice lacking all R7-RGS com-
plexes exhibit abnormal Purkinje cell maturation and dendritic
arborization, delayed morphological development of the hip-
pocampus, and increased ectopic granule cells in the hip-
pocampus (10). These postnatal neurological phenotypes
potentially could be caused in part by diminished G12/13 signal-
ing, which controls similar processes during embryonic brain
development. For example, conditional ablation of G13 and its
paralog G12 in the nervous system causes overmigration of
cortical plate and Purkinje neurons in embryonic mice (41).
Accordingly, increased ectopic granule cells in the hippocam-
pus of mice lacking all R7-RGS complexes might arise from
overmigration of these cells because G13 activity is reduced
and fails to provide sufficiently strong migratory “stop” signals,
similar to what occurs for cortical plate neurons and cerebellar
Purkinje cells in embryonic G13/ mice. Further evidence
linking G13 and R7-RGS complexes is provided by the obser-
vation that G13 mRNA is up-regulated in cerebellum of 2-
week-old postnatal mice lacking all R7-RGS complexes (11)
potentially to compensate for diminished G13 signaling activ-
ity caused by the absence of R7-RGS complexes.
Establishing the biological functions of G13 signaling regu-
lated by R7-RGS heterotrimers will require understanding the
molecularmechanisms involved. Althoughmuch remains to be
learned, we suggest two mechanistic hypotheses (Fig. 7), which
are not mutually exclusive; other models also can be imagined.
Both models are consistent with our findings that R7-RGS het-
erotrimers can interact with G13 regardless of its activity state
and that this interaction is augmented by G13-regulated Rho-
GEFs. In the first model, R7BP-bound R7-RGS heterotrimers
interactwithG13 to facilitate RhoGEF signaling that promotes
neurite retraction (46). Consistentwith thismechanism, target-
ing p115RhoGEF to the plasmamembrane by appending a pre-
nylation motif triggers neurite retraction in PC12 cells (46),
which express R7BP and R7-RGS complexes (55). In a second
model, R7-RGS heterotrimers are proposed to augment neurite
retraction by inhibiting deactivation of G13 via the GAP activ-
ity of RGS domain-containing RhoGEFs. This model is sug-
Figure 6. RH-RhoGEFs enhance interaction between G13 and R7-RGS
heterotrimers. A, split-luciferase complementation between G13(Q/L)-
CBGN and CBGC-FLAG-G5 co-expressedwith HA-RGS7 and FLAG-R7BPwith
or without Myc-LARG, His-Myc-PDZ-RhoGEF, or Myc-p115RhoGEF. Each box
represents a data point from one of four independent experiments. B, repre-
sentative Myc Western blot (WB) showing Myc-LARG, His-Myc-PDZ-RhoGEF,
andMyc-p115RhoGEFprotein expression levels for conditions used inA. Error
bars indicate standard deviation of the mean. Statistical significance was
determined using two-tailed, two-sample Student’s t test assuming equal
variance as deemed appropriate by F-test analysis. **, p 0.01; ***, p 0.001;
****, p 0.0001.
Figure 7.Models for enhancement of G13-evoked neurite retraction by
R7-RGS heterotrimers. R7-RGS heterotrimers form macromolecular com-
plexes with G13 heterotrimers and remain bound to G13 upon activation of
the G protein. Activated G13 recruits a RhoGEF to the plasma membrane
where it activates RhoA and downstream signaling events that ultimately
result in neurite retraction. RhoGEFs also negatively regulate this process
because they are GAPs for G13. R7-RGS heterotrimers could facilitate G13-
evoked neurite retraction by two non-mutually exclusive mechanisms: 1)
enhancing recruitment and activation of RhoGEFs, thereby enhancing RhoA
signaling, or 2) inhibiting RhoGEF GAP activity for G13, thereby prolonging
G13 activity.
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gested by evidence that certain RGS domains possess allosteric
inhibitory sites distal to the surface that binds G subunits to
stimulate GTP hydrolysis (56, 57). Whether such inhibitory
sites exist in the RGS domains of G12/13-activated RhoGEFs
and are targeted by R7-RGS complexes remains to be inves-
tigated. Distinguishing between these two models would
require determining whether R7BP-bound R7-RGS com-
plexes regulate the activation or deactivation of G13 and
RhoGEFs in vitro.
WhetherG12/13 signaling is facilitated similarly by complexes
containing any R7-RGS isoform is unclear. Although we found
that G13 can interact with heterotrimers containing any
R7-RGS subtype, our functional studies were limited to N2a
cells inwhichRGS7 appears to be the principal R7-RGS isoform
expressed.3 Indeed, biological processesmediated by distinct G
protein subtypes can be regulated by distinct R7-RGS isoforms
as indicated by studies of the R7-RGS proteins Egl-10 and
Eat-16 in C. elegans (25). Thus, it would be important to deter-
mine whether G12/13 signaling also can be augmented by
R7-RGS heterotrimers bearing RGS6, -9, or -11.
R7-RGS heterotrimers alsomay control neuritemorphogen-
esis by regulating signaling mechanisms independent of G13.
This hypothesis is suggested by our finding that the neurite
morphogenesis deficit of serum-starved R7BP-expressing N2a
cells was rescued incompletely by expression of the G12/13
inhibitor HA-p115RGS. In contrast, LPA-evoked neurite
retraction absolutely required G12/13 signaling as indicated by
complete blockade of this process by HA-p115RGS. Further
studies will be required to determine precisely how R7-RGS
heterotrimers regulate neurite morphogenesis by G13-depen-
dent and -independent mechanisms.
In conclusion, we have identified a novel interaction between
R7-RGS heterotrimers and G13 and provided evidence that
R7-RGS heterotrimers augment the function of G13 as a reg-
ulator of neurite morphogenesis. Our findings expand under-
standing of R7-RGS heterotrimers as multifunctional com-




The following commercially produced antibodies were used:
mouse anti-GAPDH (GeneTex, catalog number GTX627408,
lot 40953), mouse anti-FLAG M2 (Sigma, catalog number
F1804, various lots), mouse anti-actin C4 (Millipore, catalog
number MAB1501, lot NG1812617), mouse anti-EE (Covance,
catalog number MMS-115P, lot E12BF00285), mouse anti-
HA.11 (Covance, catalog number MMS-101R), mouse anti-
Myc 9E10 (Covance, catalog number MMS-150R, lot
139023001), HRP-conjugated goat anti-mouse IgG (Thermo
Scientific, catalog number 31430, various lots), HRP-conju-
gated goat anti-rabbit IgG (Thermo Scientific, catalog number
31460, various lots), and Alexa Fluor 488-conjugated goat anti-
mouse IgG (Invitrogen, catalog number A11001, lot 481679).
Our rabbit anti-R7BP polyclonal antibody has been described
(5). Rabbit anti-G5 (ATDG) and rabbit anti-RGS7 (R4613)
antibodies were generous gifts from Drs. William Simonds and
TheodoreWensel, respectively (58, 59). Other reagents were as
follows: Complete protease inhibitor mixture tablets (Roche
Applied Science, catalog number 11697498001), mouse anti-
FLAG M2-agarose (Sigma, catalog number A-2220), DSS
(ThermoScientific, catalog number 21555), StrepTactin Super-
flow (IBA, catalog number 2-1206-002), D-desthiobiotin solu-
tion (IBA, catalog number 2-1000-025), 3xFLAG peptide
(Sigma, catalog number F4799), SYPRORuby stain (Sigma, cat-
alog number S4942), Dual-Luciferase Reporter Assay System
(Promega, catalog number E1960), LPA (Avanti Polar Lipids,
catalog number 857130P), rhodamine-conjugated phalloidin
(Life Technologies, catalog number R415), poly-D-lysine
(Sigma, catalog number P0899), pertussis toxin (Calbiochem,
catalog number 516561), forskolin (Sigma, catalog number
F6886), andWIN 55,212-2 (Sigma, catalog number W102). All
remaining reagents were from Sigma unless noted otherwise.
Generation of SF-R7BP transgenicmice
All procedures involving mice were conducted under proto-
cols approved by the Animal Studies Committee of Washing-
ton University School of Medicine. To generate mice express-
ing SF-R7BP in neurons, a vector was generated to target
SF-R7BP under control of the mouse prion promoter to the
Hprt locus on the X chromosome. The backbone of the target-
ing vector was a modified version of pHPRT-targeting-Tet-
EGFP-protein-entry (generously provided byDr.Andrey Shaw)
inwhich everything between theHPRT-targeting arms (includ-
ing the Tet promoter and GFP) was replaced with a multiple
cloning site and a PGK-Neo cassette. A transgene consisting of
the mouse prion protein (MoPRP) promoter, MoPRP 5	-in-
tronic sequence, SF-R7BP, and MoPRP 3	-untranslated region
was inserted in reverse orientation in the multiple cloning site
of the parent targeting vector. The MoPRP sequences were
originally from the MoPrPXhoI plasmid (34), and the SF tag
sequence was originally from N-SF-TAP-pcDNA3 (a gift from
Dr. Christian Johannes Gloeckner; Ref. 60). Standard methods
were used to transfect ES cells with the targeting construct by
electroporation (Washington University Murine Embryonic
Stem Cell Core). Homologous recombination of the transgene
causes deletion of exon 1 of Hprt, resulting in loss of HPRT
protein expression and resistance to 6-thioguanine. Homolo-
gous recombinants were selected using both G418 and 6-thio-
guanine. ES cells that survived the selection process were con-
firmed as homologous recombinants by PCR using a forward
primer specific for the PGK-Neo cassette on the transgene and
a reverse primer specific for an HPRT genomic sequence out-
side of the right targeting arm. ES cells that were positive in the
PCR test and had a normal karyotype were used for injection
into C57BL/6 mouse blastocysts (Washington University
School of Medicine, Department of Pathology Microinjection
Core Facility) to generate chimeric mice. Chimeric male mice
were bred with female C57BL/6 mice (Charles River) to pro-
duce offspring that were screened for germ line transmission by
PCR. Mice positive for the SF-R7BP transgene were crossbred
with R7BP/ mice (50) to generate R7BP
/ offspring that
3 S. L. Scherer, M. D. Cain, S. M. Kanai, K. M. Kaltenbronn, and K. J. Blumer,
unpublished data.
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also contained the SF-R7BP transgene. These offspring were
subsequently crossed to generate R7BP/mice that were pos-
itive for the SF-R7BP transgene. Because endogenous R7BP is
not expected to affect the makeup of the protein interaction
profile, SF-R7BP male mice with both R7BP
/ and R7BP/
backgrounds were used for TAP experiments based on
availability.
Cell culture and transfection
All cells were maintained in DMEM/F-12 (Gibco, catalog
number 11330-032) supplemented with 10% (v/v) FBS (Atlanta
Biologicals, catalog number S11150) and penicillin/streptomy-
cin at 37 °C with 5% CO2 in a humidified incubator. Growth
medium for 3xFLAG-R7BP stable cells also contained 200
g/ml Geneticin (Gibco, catalog number 10131). Chemical
cross-linking experiments used a previously described clonal
derivative of N2a cells stably expressing 3xFLAG-R7BP (5).
Microscopy experiments used N2a cells transfected with
3xFLAG-R7BP (17) and treated with 400 g/ml Geneticin for
16 days to select cells that stably express 3xFLAG-R7BP. Trans-
fections were performed using TransIT-LT1 transfection re-




 was the backbone for all constructs unless
stated otherwise. CBGN-G fusion sequences weremade using
overlap extension PCR to insert a glycine/serine linker (GGG-
SSGGG) followed by CBGN and another glycine/serine linker
(GGGSSGGG) into G13 and Gq between residues 135 and
136 and between residues 124 and 125, respectively. Split-lucif-
erase fragments were amplified from plasmids containing frag-
ments of click beetle green 99 luciferase (CBGN, amino acids
2–412; CBGC, amino acids 396–542; generous gifts from Dr.
David Piwnica-Worms; Ref. 36). Human G13 and Gq were
amplified from plasmids purchased from Missouri University
of Science and Technology cDNA Resource Center. Constitu-
tively active point mutants (Q226L) of G13-CBGN and Gq-
CBGN were generated using site-directed mutagenesis. G13-
CBGN-EE was generated using overlap extension PCR to
mutate G13 amino acids 188–193 fromDYIPSQ to EYMPTE.
CBGC-LARGRGSwas created using overlap extension PCR to
splice CBGC followed by a glycine/serine linker and BglII re-
striction site to sequences encoding the RGS domain of human
LARG (amino acids 348–558). CBGC-RGS2 was constructed
by splicing CBGC followed by a glycine/serine linker and
3xFLAG sequence to sequences encoding the N terminus of
human RGS2. CBGC-3xFLAG-G5 was generated by first con-
structing a plasmid containing CBGC followed by a glycine/
serine linker and a 3xFLAG sequence immediately upstream of
the multiple cloning site of pcDNA3.1
. The coding sequence
of the short isoform of human G5 (G5s) was inserted in-
frame into this plasmid. A plasmid that expresses plasmamem-
brane-localized HA-p115RGS was constructed by using over-
lap extension PCR to fuse sequences encoding a glycine/serine
linker followed by the last 20 amino acids of human H-Ras to
the C terminus of HA-p115RGS (amino acids 1–252 of human
p115RhoGEF). The plasmid expressing 3xFLAG-R7BP has
been described (17). All newly described constructs were
verified by DNA sequencing. Published plasmids expressing
Renilla luciferase andHA-tagged R7-RGS proteins were gener-
ous gifts from Drs. David Piwnica-Worms and T. Kendall
Harden, respectively. Plasmids expressing Myc-LARG, His-
Myc-PDZ-RhoGEF, and Myc-p115RhoGEF were generous
gifts from Dr. Tohru Kozasa. The plasmid expressing Epac-
SH187 cAMP FRET sensor was generously provided by Dr. Kees
Jalink (61).
In-cell chemical cross-linking
Wild-type N2 cells or N2a cells stably expressing 3xFLAG-
R7BP were trypsinized, pelleted, and washed twice with PBS.
Cross-linking reagents were prepared just before use by
making a 200 mM stock of DSS in DMSO and then diluting in
100 mM HEPES (pH 8) for a final working solution of 1 mM
DSS in 5% (v/v) DMSO. Cells were suspended in 1 mM DSS
solution at 2.2  106 cells/ml and incubated for 30 min at
room temperature. Cross-linking reactions were quenched
by adding 20 mM Tris (pH 7.4) and incubating for 15 min at
room temperature. Cells were then pelleted and lysed for
immunoprecipitation.
Immunoblotting and immunoprecipitation
The following immunoprecipitation protocol was used for
the data shown in Fig. 1A. Cells were lysed in radioimmune
precipitation assay buffer (150 mM NaCl, 10 mM sodium phos-
phate, 1% (w/v) sodium deoxycholate, 1% (v/v) IGEPAL
CA-630, 0.5% (w/v) SDS, 1 mMDTT, Complete protease inhib-
itor mixture) by agitating for 30min at 4 °C and then cleared by
ultracentrifugation at 100,000  g for 10 min at 4 °C. Cross-
linked species containing 3xFLAG-R7BPwere immunoprecipi-
tated by incubating with mouse anti-FLAGM2-agarose for 2 h
at 4 °C followed by three washes with radioimmune precipita-
tion assay buffer and eluted by boilingwith 2 SDS-PAGE sam-
ple buffer (50 mM Tris (pH 6.8), 2% (w/v) SDS, 10% (v/v) glyc-
erol, 1% (v/v) 2-mercaptoethanol, 12.5 mM EDTA, 0.02% (w/v)
bromphenol blue) for 10 min.
Tissue lysates for experiments shown in Fig. 1C were gener-
ated by the following protocol. Mice were euthanized by
asphyxiation with CO2 followed by cervical dislocation. The
indicated tissues were isolated, and brains were further dis-
sected in Hanks’ balanced salt solution (Gibco, catalog number
14175) followed by homogenization in TAP lysis buffer (30 mM
Tris (pH 7.4), 150 mM NaCl, 0.5% (v/v) IGEPAL CA-630, 0.5%
(w/v) deoxycholate, Complete protease inhibitor mixture)
using a Dounce homogenizer and then transferred to tubes
and rotated end-over-end for 30 min at 4 °C. Lysates were
cleared by ultracentrifugation at 100,000  g for 15 min at
4 °C. A Bradford assay was performed to determine total
protein content in the cleared lysates to equalize protein
loading for SDS-PAGE.
All Western blot analyses were performed according to the
following protocol. Samples were separated by SDS-PAGE,
transferred to PVDF (Millipore, catalog number IPVH00010),
blocked for at least 1 h using 5% (w/v)milk inTBST (25mMTris
(pH 7.2), 150 mM NaCl, 2.7 mM KCl, 0.1% (v/v) Tween 20),
incubated with the indicated primary antibody in blocking
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buffer for at least 2 h, washed three times with TBST, incubated
for 1 h with appropriate HRP-conjugated secondary antibodies
diluted in blocking buffer, and washed three times with TBST.
Signals were detected using ECL solution (GE Healthcare, cat-
alog number RPN2106, or Bio-Rad, catalog number 170-5060)
and either film or a ChemiDoc Imaging System (Bio-Rad). In
some cases after image acquisition, membranes were rinsed,
reblocked, and probed for another protein. All quantified
Western blot signals were within the linear range of the
detection system as determined by an independent standard
curve.
Tandem affinity purification
TAP was performed as described previously with following
modifications (32). Three adult male mice expressing SF-R7BP
(one R7BP/ and two R7BP
/) were euthanized by asphyx-
iation with CO2 followed by cervical dislocation. All subse-
quent steps were performed on ice or at 4 °C. Whole brains
were dissected, homogenized with a Dounce homogenizer in
lysis buffer (30 mM Tris (pH 7.4), 150 mM NaCl, 0.5% (v/v)
IGEPAL CA-630, 0.5% (w/v) deoxycholate, Complete protease
inhibitor mixture), rotated end-over-end for 30min, cleared by
ultracentrifugation at 100,000 g for 15 min, and cleared fur-
ther by passing through a 0.22-m polyethersulfone filter.
Cleared lysates were incubated with StrepTactin resin over-
night with end-over-end rotation and washed five times in
batch with a 10 column volume of wash buffer (30 mM Tris
(pH 7.4), 150 mM NaCl, 0.1% (v/v) IGEPAL CA-630, Complete
protease inhibitor mixture). Protein complexes were eluted
two consecutive times by incubating with 3 column volumes
of elution buffer (1 desthiobiotin buffer E (IBA), 0.1% (v/v)
IGEPAL CA-630, Complete protease inhibitor mixture) for
30min inbatch. StrepTactin elution fractionswere combined and
incubated with anti-FLAG M2-agarose in batch for 1 h and
washed five times in batch with 10 column volumes of wash
buffer. Protein complexes were eluted from FLAG-agarose by
incubating with 4 column volumes of FLAG elution buffer
(200g/ml 3xFLAGpeptide inwash buffer) for 30min in batch.
The final eluate was concentrated in preparation for gel elec-
trophoresis using an Amicon Ultra-0.5 10,000 centrifugal filter
device (Millipore, catalog number UFC501008).
LC-MS/MS
Mass spectrometry analysis was performed by the Proteom-
ics and Mass Spectrometry Facility at the Donald Danforth
Plant Science Center (St. Louis, MO). The final TAP eluate
described abovewas resolved by SDS-PAGE, and protein bands
were visualized with SYPRO Ruby (Fig. 2C). Prominent bands
were excised, and proteins were digested using trypsin and
Glu-C and analyzed by LC-MS/MS using a 1-h gradient and an
LTQ-Orbitrap mass spectrometer. Peak lists were generated
using Mascot Distiller version 2.4. Mass spectrometric data
were searched using Mascot version 2.4.1 search engine and
NCBInr Mammalia database (April 2013 version; 1,392,029
entries). The following parameters were used: trypsin and
Glu-C allowed proteases, two missed cleavages allowed, no
fixedmodifications allowed,
16 onMet (oxidation) allowed as
a variable modification, 15-ppm mass tolerance for precursor
ions, and 0.80-Da mass tolerance for fragment ions. The data-
base cRAP_20110301 (118 entries) was used to exclude known
contaminants. Scaffold (version 4.0.5) was used to validate
peptide and protein identities. Peptide identifications were
accepted if they could be established at greater than 80% prob-
ability by the Scaffold local false discovery rate algorithm. All
reported proteins have at least 99% protein identification prob-
abilities as determined using the Protein Prophet algorithmand
at least two exclusive unique peptides assigned. Proteins that
contained similar peptides and could not be differentiated
based on MS/MS analysis alone were grouped to satisfy the
principles of parsimony. Proteins sharing significant peptide
evidence were grouped into clusters. Glu-C, trypsin, and kera-
tin proteins were removedmanually from the results. Reported
are the proteins identified from a single TAP experiment start-
ing with three SF-R7BP mouse brains.
Split-luciferase complementation
HEK293 cells were plated in 24-well dishes and transfected
the next day with the indicated split-luciferase plasmids,
Renilla luciferase for signal normalization, GFP to assess trans-
fection efficiency, and pcDNA to normalize total DNA
amounts across samples. At least three replicate wells of cells
were transfected per condition in each independent experi-
ment. Luciferase assayswere performed 24–26 h after transfec-
tion using the Dual-Luciferase Reporter Assay System accord-
ing to the manufacturer’s protocol. A GloMax96 luminometer
equipped with two injection pumps was used to measure lucif-
erase activity on a per-well basis by first injecting the substrate
solution for CBG and then injecting a quencher for click beetle
green as well as the substrate for Renilla luciferase. Data collec-
tion started 0.4 s after substrate additionwith a 10-s integration
time.
Fluorescencemicroscopy
Formicroscopy experiments using HA-p115RGS, cells were
transfected and then replated the next day at low density on
poly-D-lysine (PDL)-coated glass coverslips. For experiments
not requiring transfection, cells were simply plated at low den-
sity on PDL-coated glass coverslips. Three hours after plating,
the medium was exchanged for differentiation medium
(DMEM/F-12 plus penicillin/streptomycin). For experiments
using PTX, cells were plated at low density on PDL-coated glass
coverslips and treated with 100 ng/ml PTX overnight. The next
morning, the medium was exchanged for differentiation
medium containing 100 ng/ml PTX, and this was repeated
again 24 h later. In all cases, cells were allowed to differentiate
for 48 h. If indicated, cells were treated with various concentra-
tions of LPA (in 5 mg/ml fatty acid-free BSA in DPBS) for 15
min prior to fixing. Cells were fixed by incubationwith 4%para-
formaldehyde inDPBS (pH7.2) for 10min at room temperature
followed by washes with DPBS. Fixed cells were permeabilized
with 0.5% (v/v) Triton X-100 in DPBS for 10 min at room tem-
perature, washed with DPBS, and blocked with blocking buffer
(1% (w/v) BSA, 0.1% (v/v) Tween 20 inDPBS) for at least 30min
at room temperature. If immunostaining was required, cover-
slips were incubatedwith primary antibody (diluted in blocking
buffer) in a humidified chamber overnight at 4 °C, washed three
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times with wash buffer (0.1% (v/v) Tween 20 in DPBS), and
incubated with appropriate Alexa Fluor-conjugated secondary
antibody and rhodamine-conjugated phalloidin in a humidified
chamber for 1 h at room temperature. For experiments that did
not require immunostaining, rhodamine-phalloidin was incu-
bated with the coverslips for 30min in a humidified chamber at
room temperature immediately following the permeabilization
step. All coverslips were washed three times with wash buffer,
rinsed briefly in water, and mounted on glass slides using
Vectashield mounting medium. Microscopy images were
acquired with an Olympus IX81 inverted fluorescence micro-
scope equippedwith aUPlanSApo 60 oil objective (numerical
aperture, 1.35) and an EXi BLUE digital camera (Q Imaging).
Images were acquired using MetaMorph for Olympus Ad-
vanced and processed using Fiji software. Brightness and
contrast were adjusted on an entire-image basis. Images of rho-
damine-phalloidin fluorescencewere used to score neurite pro-
jections, defined as any process extending from the cell body
that was longer than half the cell body length. Cell body lengths
were measured using the line tool, and neurite lengths were
measured using the segmented line tool in Fiji.
cAMP FRET sensor assay
N2a cells were transfected with the Epac-SH187 cAMP FRET
sensor.After 24 h, cellswere trypsinized and replated in a black-
wall clear-bottom 96-well plate (Costar, catalog number 3603)
coated with poly-D-lysine. Cells were incubated in serum-free
mediumwith or without 100 ng/ml pertussis toxin for 16–24 h.
Prior to imaging, growth medium was replaced with pre-
warmed (37 °C) imaging buffer (125nMNaCl, 5mMKCl, 1.5mM
MgCl2, 1.5 mM CaCl2, 10 mM D-glucose, 20 mM HEPES (pH
7.4)) and assayed immediately using a Synergy H4 Hybrid
Reader (BioTek) equippedwith injection pumps for adding for-
skolin and WIN 55,212-2. Cells were maintained at 37 °C
throughout the recording period. FRET donor was excited
using a xenon flash lamp and a 420/20 bandpass filter. Donor
emission and acceptor emission were detected every 10 s using
480/20 and 540/20 bandpass filters, respectively. A dichroic
mirror with a 455-nm cutoff was used to separate the excitation





FRET ratio baseline FRET ratio
baseline FRET ratio
(Eq. 1)
where FRET ratio  (480 nmemission/540 nmemission) at a giv-
en time point and the baseline FRET ratio  average (480
nmemission/540 nmemission) prior to forskolin stimulation. Trip-
licate wells were assayed per condition in each independent
experiment.
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